This article revisits the original cost-effectiveness that was done for the DEC report and brings in other factors such as reduction of falls. The same analysis is also applied to the STIMuSTEP. The QALY analysis shows that the ODFS and STIMuSTEP (implanted drop foot system) are cost effective devices within the terms set out by the National Institute for health and Clinical Excellence (NICE) .
cost_benefit_paper_4.pdf